Moderna, Inc. MRNA
$56.97
▲ +0.54% 24H
About
Moderna, Inc. is a biotechnology company specializing in the development of transformative medicines using messenger ribonucleic acid (mRNA) technology. Its primary focus lies in creating innovative therapeutics across multiple modalities, including prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology t…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees4,700
TickerMRNA
Statistics
Market Cap$22.59B
Revenue (TTM)$1.94B
Net Income-$2.82B
Net Margin-145.2%
EPS$-7.26
P/E24.97
P/S8.85
P/B2.66
EV/EBITDA-6.24
ROE-36.6%
Dividend Yield—
Price$56.97
Data: Twelve Data · Revenue = mcap / P/S